Zhou Xianfeng, Liu Bin, Yu Xianghui, Zha Xiao, Zhang Xizhen, Wang Xueyun, Chen Yu, Chen Yan, Chen Yue, Shan Yaming, Jin Yinghua, Wu Yongge, Liu Junqiu, Kong Wei, Shen Jiacong
College of Life Science, Key Laboratory for Supramolecular Structure & Materials of Ministry of Education, Jilin University, Changchun 130012, and Sichuan Tumor Hospital & Institute, Chengdu, PR China.
Biomaterials. 2007 Nov;28(31):4684-92. doi: 10.1016/j.biomaterials.2007.07.002. Epub 2007 Aug 7.
DNA vaccination has tremendous potential for treating or preventing numerous diseases for which traditional vaccines are ineffective but the technique can be limited by low immunogenicity. Current synthetic DNA delivery systems are versatile and safe, but substantially less efficient than viruses. Here, a novel multicomponent supramolecular system involving the preparation of mannose-bearing chitosan oligomers microspheres with entrapping complexes of DNA vaccine and polyethylenimine was developed to mimic many of the beneficial properties of the viruses. After delivery by intramuscular immunization in BALB/c mice, the microspheres induced an enhanced serum antibody responses two orders of magnitude greater than naked DNA vaccine. Additionally, in contrast to naked DNA, the microspheres induced potent cytotoxic T lymphocyte responses at a low dose. Consequently, formulation of DNA vaccines into multicomponent vectors is a powerful means of increasing vaccine potency.
DNA疫苗在治疗或预防众多传统疫苗无效的疾病方面具有巨大潜力,但该技术可能会受到免疫原性低的限制。当前的合成DNA递送系统用途广泛且安全,但效率远低于病毒。在此,开发了一种新型多组分超分子系统,该系统涉及制备带有甘露糖的壳聚糖低聚物微球,并包裹DNA疫苗与聚乙烯亚胺的复合物,以模拟病毒的许多有益特性。在BALB/c小鼠中进行肌肉注射免疫递送后,微球诱导的血清抗体反应增强,比裸DNA疫苗高两个数量级。此外,与裸DNA相比,微球在低剂量时就能诱导强大的细胞毒性T淋巴细胞反应。因此,将DNA疫苗制备成多组分载体是提高疫苗效力的有力手段。